the bioavailability of chloramphenicol and the pharmacokinetics of chloramphenicol and chloramphenicol succinate were studied in 5 premature infants ( group a ) , 8 full-term infants ( group b ) and 4 children ( group c ) receiving intravenous chloramphenicol succinate at steady-state .
C0021270
infants
C0008059
children